The Mounjaro vs Wegovy UK question is rarely answered by looking at the first monthly price alone. Both are prescription-only weight-management medicines, and both require a proper assessment by a UK-registered prescriber. But the provider behind the prescription can materially change what you pay, how you are monitored and what happens if treatment is not suitable.

For anyone comparing private options, the useful question is not simply, “Which is cheaper?” It is: “What medicine has the clinician decided is appropriate, and what does the full service cost over time?” A low headline price can exclude clinical reviews, delivery, medication at later stages, cancellation terms or support that another provider includes.

Mounjaro vs Wegovy UK: the core differences

Mounjaro contains tirzepatide and Wegovy contains semaglutide. They are different medicines, although both are used within licensed weight-management care alongside reduced-calorie eating and increased physical activity. They are administered as regular injections, but they do not work in exactly the same way.

Tirzepatide acts on two hormone pathways involved in appetite and blood-glucose regulation. Semaglutide acts on one of those pathways. That distinction is clinically relevant, but it does not make one medicine automatically the right choice for every person. A prescriber will consider your medical history, current medicines, treatment goals, contraindications and the licensed criteria before making any decision.

It is also worth separating medical choice from provider choice. One online clinic may offer both medicines, while another may offer only one. That does not mean the medicine it sells is necessarily the best clinical fit. Never use a provider that cannot clearly confirm the identity and registration of its prescriber and dispensing pharmacy.

What a regulated provider should assess

A legitimate online assessment is more than a checkout form. It should gather enough information for a clinician to decide whether prescribing is appropriate and safe. Depending on the circumstances, this can include your weight and health history, existing conditions, current medication, previous weight-management treatment and relevant lifestyle information.

The prescriber may ask for further evidence, request a video consultation, decline treatment or recommend that you speak to your GP or another healthcare professional. Those are not signs of poor service. They are signs that the provider is treating prescription medicine as medical care rather than a consumer product.

Be wary of sites that promise approval before reviewing your information, make dramatic outcome claims, or are vague about who makes prescribing decisions. In the UK, a registered clinician must independently assess suitability. Comparison tools can help you compare services, but they cannot replace that assessment.

Comparing Mounjaro and Wegovy costs fairly

The advertised starting price is often the least useful figure on a provider’s page. Prices can change as treatment progresses, and the amount charged may depend on the medicine, treatment stage and service model. What looks cheap at the beginning can become considerably more expensive after the initial period.

Use the same questions for every provider you compare:

| Check | Why it matters | |---|---| | Price at each treatment stage | The ongoing charge may be higher than the introductory price. | | Consultation and prescribing fees | Some services include them; others charge separately. | | Delivery and dispensing charges | A monthly fee may not cover postage or pharmacy costs. | | Clinical reviews and follow-up | Check how often reviews are included and whether they cost extra. | | Support offered | Coaching, messaging and clinician access vary widely. | | Cancellation and refund terms | You may not be able to cancel or receive a refund once medication has been dispensed. |

Ask whether the price shown includes the specific medicine and treatment stage you are comparing. A provider quoting a broad “from” price may be referring to a limited introductory offer rather than the cost you will pay later.

Subscription arrangements deserve particular attention. Some providers use rolling monthly plans; others require you to actively pause or cancel before the next payment date. Check whether there is a minimum commitment, whether a consultation fee is refundable if you are not approved, and what happens if there is a supply issue. Clear terms are part of safe, transparent care.

Side effects and safety are not a footnote

Like all medicines, Mounjaro and Wegovy can cause side effects. Gastrointestinal effects such as nausea, vomiting, diarrhoea, constipation and stomach discomfort are commonly discussed with patients. The likelihood and impact vary between individuals, which is one reason clinical oversight matters.

A provider should give clear safety information, explain when to seek medical help and offer a way to contact its clinical team about concerns. It should also make clear that treatment may need to be reviewed, paused or stopped if it is unsuitable or poorly tolerated. Do not treat an online questionnaire as a substitute for reading the patient information supplied with the prescribed medicine.

Both medicines may be unsuitable for some people or require particular caution alongside certain health conditions or medicines. That is not something a comparison article can determine. Be accurate and complete in your assessment, including when you disclose prescription medicines, over-the-counter products and supplements.

Supply, delivery and continuity of care

Private treatment is not just about receiving the first delivery. Before choosing a provider, ask how it handles ongoing prescribing, clinical follow-up and potential supply disruption. Medicines should come from an appropriately regulated pharmacy, be supplied in suitable packaging and include the necessary information for safe use and storage.

Avoid social-media sellers, marketplace listings and informal “spare pen” offers. A product may be counterfeit, mishandled, expired or not what it claims to be. You also lose the clinical accountability that should sit behind prescription treatment.

It is reasonable to expect a provider to explain delivery timeframes, what happens if a parcel is delayed and how to contact support. However, no provider can guarantee a prescription or uninterrupted supply in every situation. If a site promises either without qualification, treat that as a warning sign.

Which comparison points actually matter?

For some people, lower ongoing cost is the deciding factor. For others, it is the ability to speak to a clinician, a more structured support service, faster dispatch after approval or simple cancellation terms. None of those priorities is wrong, but they should be visible before you commit.

A like-for-like comparison should put the medicine, treatment stage, monthly total, consultation model and contract terms in the same view. PickMyClinic is designed to help users compare those provider-set details before they begin a medical assessment, rather than relying on a single headline price.

Brand recognition can be reassuring, but it should not replace due diligence. Check that the provider clearly identifies its clinical and pharmacy arrangements, explains the full cost and publishes realistic policies on approvals, delivery and refunds. If you cannot find those details easily, ask before paying.

A clearer way to make the decision

The Mounjaro vs Wegovy UK comparison starts with different active ingredients, but it should end with a regulated clinician deciding what is appropriate after assessment. Your role is to choose a provider that is transparent about its service and costs, and to give accurate information so that decision can be made safely.

Take the extra few minutes to compare the total monthly cost rather than the opening offer. The best value is not necessarily the lowest number on the first page - it is care that is legitimate, clearly priced and still workable if your circumstances or treatment plan change.